Research brings hope for the future
“All the promising research makes you feel like there is light at the end of that very dark tunnel after all.”
Search results
“All the promising research makes you feel like there is light at the end of that very dark tunnel after all.”
After more than 10 years of service as Chair of the Board of Trustees, Don Grocott has retired.
Our Director of Development, Paula McGrath, recently appeared on RNIB Connect to talk about our new Unlock Genetics resource. You can listen to the show online here:
We are proud to announce that Amar Latif - adventurer, entrepreneur, TV presenter and public speaker - is to join Retina UK as a volunteer ambassador.
High quality information on genetic testing and counselling for families affected by inherited sight loss is now available in one place thanks to the launch of an innovative new website, Unlock Genetics.
Choroideremia is a rare genetic condition resulting in progressive sight loss in men.
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
Lockdown may have put the brakes on Euroglaze’s fundraising campaign for Retina UK initially, but the team at the Barnsley based Rehau fabricator are now on a roll once again.
Despite the challenges of the pandemic, researchers and pharmaceutical companies are still making progress towards delivering new treatments for inherited sight loss.
The team have found the cause of disease in the first ever family tree drawn up at Moorfields Eye Hospital over 35 years ago, which had remained unsolved until now.